MyFinsight
Home
About
Contact
pcrx: the income statement
Download
Download image
Bupivacaine Liposome
Injectable Suspension
$2,691K
Iovera
$6,465K
ZILRETTA
$28,982K
EXPAREL
$139,902K
Royalty
$1,476K
Product
$178,040K
Interest income
$8,534K
(55.67%↑ Y/Y)
Total revenues
$179,516K
(6.49%↑ Y/Y)
Total other income
(expense), net
$3,162K
(371.24%↑ Y/Y)
Income (loss) from
operations
$6,362K
(104.56%↑ Y/Y)
Other, net
-$110K
(9.84%↑ Y/Y)
(loss) gain on early
extinguishment of debt
-$983K
Interest expense
$4,279K
(-8.74%↓ Y/Y)
Total operating
expenses
$173,154K
(-43.80%↓ Y/Y)
Income (loss) before
income taxes
$9,524K
(106.86%↑ Y/Y)
Contingent consideration
charges (gains),...
$6,791K
Amortization of acquired
intangible assets
$14,322K
(0.00%↑ Y/Y)
Selling, general and
administrative
$91,797K
(23.49%↑ Y/Y)
Research and development
$25,966K
(35.92%↑ Y/Y)
Cost of goods sold
$34,278K
(-11.80%↓ Y/Y)
Net income (loss)
$5,432K
(103.79%↑ Y/Y)
Income tax expense
$4,092K
(-11.24%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)